Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Haas T, Spielmann N, Cushing M. Impact of incorrect filling of citrate blood sampling tubes on thromboelastometry. Scand J Clin Lab Invest. 2015;75(8):717-9.

Mosquera J-, Varma S, Pauli C, MacDonald TY, Yashinskie JJ, Varga Z, et al. MAGI3-AKT3 fusion in breast cancer amended. Nature. 2015;520(7547):E11-2.

Magro CM, Momtahen S, Mulvey JJ, Yassin AH, Kaplan RB, Laurence JC. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome. Am J Dermatopathol. 2015;37(5):349-56; quiz 357-9.

Ginter PS, Scognamiglio T, Tauchi-Nishi P, Antonio LB, Hoda SA. Pleomorphic adenoma of breast: a radiological and pathological study of a common tumor in an uncommon location. Case Rep Pathol. 2015;2015:172750.

Li Q, Li Y, Gu B, Fang L, Zhou P, Bao S, et al. Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation. J Biol Chem. 2015;290(35):21553-67.

Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, et al. Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis. 2015;36(6):632-8.

Gardner TJ, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella D. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle. Antiviral Res. 2015;113:49-61.

Srivastava A, Chopra S, Pham A, Sooriakumaran P, Durand M, Chughtai B, et al. Corrigendum re: "effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy" [Eur Urol 2013;63:438-44]. Eur Urol. 2015;68(4):744.

Geyer JT, Subramaniyam S, Jiang Y, Elemento O, Ferry JA, de Leval L, et al. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol. 2015;46(2):260-71.

Klingler S, Guo B, Yao J, Yan H, Zhang L, Vaseva AV, et al. Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Res. 2015;75(10):2109-19.